On Tuesday, Shares of EMC Corporation (NYSE:EMC), lost -3.24% to $24.02.
EMC Corporation, declared the EMC® XtremIO™ all flash array business has achieved $1 billion in aggregate bookings in just over 18 months since its commercial market debut, making it, quite possibly, the fastest-growing product in EMC’s 36-year history.
As stated in EMC’s second quarter 2015 earnings, XtremIO revenue growth exceeded 300% year over year, and remains the all-flash array market segment leader.
- XtremIO achieves $1 billion in aggregate bookings in just six quarters on the market
- Market-leading all flash array amasses over 1,750 customers, counting 60% of the Fortune 100 and 47% of the Fortune 200
EMC Corporation develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services. It offers enterprise storage systems and software deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, in addition to provides a portfolio of backup products that support a range of enterprise application workloads.
Shares of Novavax, Inc (NASDAQ:NVAX), declined -2.41% to $10.51, during its last trading session.
Novavax, Inc, a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, declared that it will host its 3rd annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m. – 11:00 a.m. ET in New York, NY.
Senior administration will conduct a series of presentations to update analysts and investors on the Company’s ongoing clinical development programs. In addition, a key opinion leader will provide a clinical perspective on respiratory syncytial virus (RSV) diseas
Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology.
Finally, Cobalt International Energy, Inc (NYSE:CIE), ended its last trade with 0.12% gain, and closed at $8.02.
Cobalt International Energy, Inc. declared that Shannon (Shane) E. Young, III will join Cobalt as Chief Financial Officer and Executive Vice President. Mr. Young is presently Senior Vice President & Chief Financial Officer for Talos Energy LLC. He replaces John P. Wilkirson, who has indicated his desire to pursue other interests. These changes are effective September 1, 2015, and Mr. Wilkirson will remain as a consultant to Cobalt through the end of October to ensure a smooth executive transition.
John Wilkirson added, “My time at Cobalt has been truly special as the company matured from the private start-up to recently’s successful public entity. During the past five years as CFO, I appreciated the opportunity to have led multiple noteworthy and innovative financings. I feel the timing is right to make this transition and I wish the company all the best in their future endeavors.”
In addition to his current role, Mr. Young has over 20 years’ experience as an Investment Banker at Goldman Sachs, Morgan Stanley, and Salomon Brothers. Mr. Young earned a Bachelor in Business Administration in Finance from The University of Texas at Austin and a Masters of Business Administration with Distinction from the Amos Tuck School of Business at Dartmouth College.
Cobalt International Energy, Inc., through its auxiliaries, engages in the exploration and production of oil-focused, below-salt exploration prospects. Its project portfolio comprises North Platte, Heidelberg, Shenandoah, and Anchor discovery in the U.S. Gulf of Mexico; Cameia, Lontra, Mavinga, Bicuar, and Orca in the offshore Angola; and Diaman in the offshore Gabon. As of December 31, 2014, the company’s estimated net proved undeveloped reserves totaled 8.4 million barrels of oil and 3.7 billion cubic feet of natural gas. Cobalt International Energy, Inc. was founded in 2005 and is based in Houston, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
